1202160-01-7

Basic information

• Product Name: (4-chlorophenyl)(4-(3-chlorophenyl)-2-trityl-1,2,3,4-tetrahydroisoquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanol
• Synonyms: (4-chlorophenyl)(4-(3-chlorophenyl)-2-trityl-1,2,3,4-tetrahydroisoquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanol
• CAS NO: 1202160-01-7
• Molecular Weight: 706.714
• Mol File: 1202160-01-7.mol

Chemical Properties

• CAS DataBase Reference: (4-chlorophenyl)(4-(3-chlorophenyl)-2-trityl-1,2,3,4-tetrahydroisoquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanol(CAS DataBase Reference)
• NIST Chemistry Reference: (4-chlorophenyl)(4-(3-chlorophenyl)-2-trityl-1,2,3,4-tetrahydroisoquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanol(1202160-01-7)
• EPA Substance Registry System: (4-chlorophenyl)(4-(3-chlorophenyl)-2-trityl-1,2,3,4-tetrahydroisoquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanol(1202160-01-7)

Safety Data

• Hazardous Substances Data: 1202160-01-7(Hazardous Substances Data)

Upstream product

• 1202160-00-6 6-bromo-4-(3-chlorophenyl)-2-trityl-1,2,3,4-tetrahydroisoquinoline 

Downstream Products

• 1202160-02-8 (4-chlorophenyl)(4-(3-chlorophenyl)-1,2,3,4-tetrahydroisoquinolin-6-yl)(1-methyl-1H-imidazol-5-yl)methanol 

Relevant articles and documents

Isoquinoline-based analogs of the cancer drug clinical candidate tipifarnib as anti-Trypanosoma cruzi agents

We developed a synthetic route to prepare isoquinoline analogs of the cancer drug clinical candidate tipifarnib. We show that these compounds kill Trypanosoma cruzi amastigotes grown in mammalian host cells at concentrations in the low nanomolar range. Th